Login to Your Account

FDA Seeks End of Road for Compounded Biologics

By Mari Serebrov
Washington Editor

Monday, March 25, 2013
If the FDA gets the authority it wants, it could be the end of the road for compounded versions of some biologics and high-risk drugs. In the aftermath of a deadly meningitis outbreak, the agency is working with lawmakers on legislation that would set stricter standards for compounding pharmacies and increase the agency's oversight.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription